Department of Nuclear Medicine and Molecular Imaging, Clinical Development Research Unit of Farshchian Heart Center, Hamadan University of Medical Sciences, Hamadan, 517839131, Iran.
Institute of Nuclear Chemistry and Technology, Dorona 16 Str, 03-195, Warsaw, Poland.
Future Oncol. 2021 Apr;17(10):1219-1235. doi: 10.2217/fon-2020-0577. Epub 2021 Feb 17.
Radioprotection is the process whereby biological systems are aided against undesirable radiation hazards. Primitive radioprotectors suffered from either having crucial side effects or low efficacy in clinical applications. Therefore, the search for less toxic but more capable radioprotectants has continued for decades. Peptides have been investigated as radioprotectants in a variety of preclinical models both and . Peptides exert their influence through scavenging free radicals, modifying cell signaling and inhibiting cell apoptosis. Demonstrating potential properties, peptide radiation countermeasures might find enough credit for use in humans in the future. This article reviews the potential therapeutic value of currently known radioprotective peptides and attempts to provide a comprehensive source for further scientific research in this area.
放射防护是指帮助生物系统抵御不良辐射危害的过程。原始的放射防护剂要么存在关键的副作用,要么在临床应用中效果不佳。因此,几十年来,人们一直在寻找毒性更小但功效更强的放射防护剂。肽已在多种临床前模型中被研究为放射防护剂。肽通过清除自由基、改变细胞信号和抑制细胞凋亡来发挥作用。展示出潜在的治疗特性,肽类辐射对策在未来可能会在人类中得到足够的应用。本文综述了目前已知的具有放射防护作用的肽的潜在治疗价值,并试图为该领域的进一步科学研究提供一个全面的资源。